Lutris, Pharma

Lutris Pharma Presents New Data from Its Completed Clinical Trial of LUT014 Gel Demonstrating Efficacy in Treating Acneiform Rash Associated with Use of Anti-EGFR Cancer Therapies at AACR Annual Meeting 2025

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Lutris Pharma Israel

View original content:https://www.prnewswire.co.uk/news-releases/lutris-pharma-presents-new-data-from-its-completed-clinical-trial-of-lut014-gel-demonstrating-efficacy-in-treating-acneiform-rash-associated-with-use-of-anti-egfr-cancer-therapies-at-aacr-annual-meeting-2025-302438996.html

en | boerse | 67958427 |